<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01409551</url>
  </required_header>
  <id_info>
    <org_study_id>Theagenio Thoracic Surgery 2</org_study_id>
    <nct_id>NCT01409551</nct_id>
  </id_info>
  <brief_title>Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions.</brief_title>
  <official_title>Video-assisted Hyperthermic Pleural Chemoperfusion Versus Bed-side Talc Slurry Pleurodesis for Refractory Malignant Pleural Effusions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theagenio Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theagenio Cancer Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to compare two methods of pleurodesis for refractory malignant pleural
      effusions, in terms of safety and efficacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study compares prospectively two groups of patients with refractory maignant pleural
      effusion. Group A consists of patients undergoing video-assisted hyperthermic pleural
      chemoperfusion (with a pump machine) and group B includes patients undergoing bed-side tube
      thoracostomy and talc slurry pleurodesis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of pleural effusion</measure>
    <time_frame>2 months following intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Postoperative period (7 days following intervention)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Safety of Intervention</condition>
  <condition>Efficacy of Intervention</condition>
  <condition>Cost Effectiveness</condition>
  <arm_group>
    <arm_group_label>VATS hyperthermic pleural chemoperfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients undergo a VATS drainage of pleural effusion with adhesiolysis and complete mobilization of the lung, following by a 1 hour hyperthermic (40oC)chemoperfusion by means of a pump machine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bedside talc slurry pleurodesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients undergo tube thoracostomy under local anesthesia. When the lung is fully expanded, talc slurry bed-side pleurodesis is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS hyperthermic chemoperfusion</intervention_name>
    <description>VATS, adhesiolysis, hyperthermic chemoperfusion (with a pump machine)</description>
    <arm_group_label>VATS hyperthermic pleural chemoperfusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bedside talc slurry pleurodesis</intervention_name>
    <description>Bedside tube thoracostomy under local anesthesia. Bedside talc slurry pleurodesis.</description>
    <arm_group_label>Bedside talc slurry pleurodesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recurrent symptomatic malignant pleural effusion

          -  No prior intrapleural therapy

          -  Abscence of bronchial obstruction or fibrosis preventing lung reexpansion

          -  No systemic chemotherapy immediately prior to or during the first 30-day interval
             following pleurodesis

        Exclusion Criteria:

          -  Poor Karnofsky Performance Status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nikolaos Barbetakis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Theagenio Cancer Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thoracic Surgery Department, Theagenio Cancer Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54007</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2011</study_first_submitted>
  <study_first_submitted_qc>August 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2011</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Theagenio Cancer Hospital</investigator_affiliation>
    <investigator_full_name>Nikolaos Barbetakis</investigator_full_name>
    <investigator_title>Head of Thoracic Surgery Department</investigator_title>
  </responsible_party>
  <keyword>Pleural effusion</keyword>
  <keyword>VATS</keyword>
  <keyword>hyperthermia</keyword>
  <keyword>thoracostomy</keyword>
  <keyword>pleurodesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Pleural Effusion, Malignant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

